tysabri 300 mg vial

Tysabri Vial is an advanced biological therapy that belongs to the class of monoclonal antibodies. It works by preventing immune cells from crossing into the brain and spinal cord, thereby reducing immune-mediated damage to nerve cells.

The medication effectively reduces the frequency of relapses and slows the progression of physical disability in patients with active relapsing multiple sclerosis. It is particularly beneficial for patients who have not responded adequately to conventional disease-modifying therapies.

Composition of Tysabri

• Natalizumab

Available Strength

• Concentrate for solution for intravenous infusion, 300 mg.

Uses of Tysabri

• Treatment of active relapsing multiple sclerosis (RMS) to reduce the frequency of relapses.

• Slows the progression of physical and neurological disability over the long term.

• Helps control inflammation within the central nervous system caused by abnormal immune activity.

• Used as an alternative treatment for patients with multiple sclerosis who have shown an inadequate response to other therapies.

Dosage

• The recommended adult dose is 300 mg administered as an intravenous infusion under the supervision of a healthcare professional.

• The dose is typically given once every 4 weeks according to the prescribed treatment schedule. Patients should adhere to the scheduled infusion appointments and should not delay or alter treatment without consulting their physician.

Side Effects

• Mild headache, fatigue, or general tiredness following the infusion.

• Increased risk of upper respiratory tract infections or urinary tract infections.

• Temporary joint or muscle pain.

• Mild infusion-related reactions, including localized allergic reactions or transient skin itching.

Contraindications

• Do not use Tysabri in patients with known hypersensitivity to natalizumab or any of the product's ingredients.

• Contraindicated in patients with progressive multifocal leukoencephalopathy (PML) or those at high risk of developing PML.

• Should not be used in patients with severely weakened immune systems, such as those with certain cancers, AIDS, or those receiving other immunosuppressive therapies, because of the increased risk of serious opportunistic infections.

Alternatives to Tysabri

• Gilenya

• Rebif

• Ocrevus

How to Use Tysabri Correctly

• Tysabri should be administered only in a hospital or specialized medical center under the supervision of experienced healthcare professionals.

• It is given as a slow intravenous infusion over the recommended period according to the prescribing information or the physician's instructions.

• Patients should be monitored during the infusion and for an appropriate period afterward to detect and manage any hypersensitivity reactions or other early adverse effects.

Storage Conditions

• Store the vial in a refrigerator at 2°C to 8°C. Do not freeze.

• Keep the vial in its original carton to protect it from light.

• Store in a secure place out of the sight and reach of children.